|
Status |
Public on Oct 02, 2014 |
Title |
Patient-derived xenograft T-ALL-29 |
Sample type |
RNA |
|
|
Source name |
Patient-derived xenograft cells
|
Organism |
Homo sapiens |
Characteristics |
host strain: NOD/SCID age at injection: xenograft cells Injected at 6-10 weeks tissue: Xenograft cells (>95% hCD45+ cells) from mouse spleens xenograft: T-ALL
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with a combination of Trizol reagent and QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA was prepared with the Illumina TotalPrep RNA kit for Illumina arrays
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Description |
patient-derived xenograft cells
|
Data processing |
The data were max-collapsed, log2-transformed and quantile normalised using GenePattern
|
|
|
Submission date |
Dec 04, 2013 |
Last update date |
Oct 02, 2014 |
Contact name |
Santi Suryani |
E-mail(s) |
[email protected]
|
Phone |
+61 2 9385 1884
|
Organization name |
Children's Cancer Institute Australia for Medical Research
|
Department |
Leukaemia Biology
|
Street address |
Level 5 Lowy Cancer Research Centre Gate 9 High St
|
City |
Sydney |
State/province |
NSW |
ZIP/Postal code |
2052 |
Country |
Australia |
|
|
Platform ID |
GPL10904 |
Series (1) |
GSE52991 |
Genome-wide analysis of basal gene expression in pediatric acute lymphoblastic leukemia xenograft cells |
|